Melatonin in Smoke-induced Vascular Injury

PHASE4CompletedINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

July 31, 2015

Study Completion Date

October 31, 2015

Conditions
SmokingVascular System Injuries
Interventions
OTHER

non-smoker oral placebo

Participants oral placebo last 2 weeks.

DRUG

non-smoker oral melatonin

Participants oral melatonin 3 mg/day last 2 weeks.

OTHER

smoker oral placebo

Participants oral placebo last 2 weeks.

DRUG

smoker oral melatonin

Participants oral melatonin 3 mg/day last 2 weeks.

Trial Locations (1)

100730

PekingUMCH, Beijing

All Listed Sponsors
lead

Peking Union Medical College Hospital

OTHER

NCT02591238 - Melatonin in Smoke-induced Vascular Injury | Biotech Hunter | Biotech Hunter